Brief: Biophytis SA Says Results Of SARA-INT Phase 2 Trial With Sarconeos In Sarcopenia To Be Released By August
30/06/2021 22:41
June 30 (Reuters) - Biophytis SA ALBPS.PA :
* RESULTS OF BIOPHYTIS SARA-INTEREST PHASE 2 TRIAL WITH
SARCONEOS
(BIO101) IN SARCOPENIA WILL BE RELEASED BY AUGUST 2021
Source text for Eikon: ID:nGNXbcY4bF
Further company coverage: ALBPS.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biophytis SA
See all newsBrief: Biophytis SA Secures $20 Mln For Launch Of Phase 3 Trial In Sarcopenia
Brief: Biophytis Secures Public Funding In Brazil For Obesity Phase 2 Trial
Brief: Biophytis SA Gets EMA Authorization For Phase 2 Clinical Trial In Obesity
Brief: Biophytis Gets EMA & Belgian Regulatory Approval For Phase 3 Sarcopenia Clinical Trial
Brief: Biophytis To Initiate Phase 2 Study In Obesity & Phase 3 Study In Sarcopenia Soon